View
220
Download
0
Category
Preview:
Citation preview
�� !kjOPJeN�� !"
Tzu Chi Med J 2004 � 16 � No. 2 �� ! NNV
� �
�� !"#$%&'NM23-H1�� !"#$%&
�� !
�� �� N
�� O
�� !"#$%&'()*+,- �� N
�� !"#$%&'()*O
�� !"VO� T� P�� !�"#VO� U� N�� !�"#VO� U� OV�
�� !"#$%&'()*+,-./01 O� �� !"#$%&'()*+,- �� !"
��
�� �� !"#$%&'(&')kjOPJeN�� !"#$%&' ()*+�� !"#�� !"#
�� ! 2000 �� 2002�� !"#$%&'()*+�,-./0123456789:;<56=>�)?
�� !"#$%&'()QS�� !E�� Z43�3�� !33ú88�� !54.32�� !"22�� 13��
�� 11 �F�� !"#$%&'()*+,-./012NM23-H1�� !"#�� 46�� !"NM23-H1
�� !"#$%&'E� 54.3% �� 25 �F�� !"#$%&'()*+,-E�� !"#$%F�� !"#
�� !"#$%&'(� !)*'(+,-.NM23-H1�� !"#$%&'()*+,-./012345
�� !"�� �� !"#NM23-H1�� !"#$%&'()*+,-./01234567%89:!"
�� !"#$"#NM23-H1�� !"#$%&'()*+,-./01234 56789:;<=$>?@
�� !"#$E�� !=2004; 16:119-124F
�� !kjOP�� !"#$�� %&' ()*+,-./
xNz�
kjOP�� !"#$%&$' NTèONKP ��
�� !"#$%&'() � EåìÅäÉçëáÇÉ=ÇáéÜçëJ
éÜ~íÉ=âáå~ëÉI=kamhFxOz�kamh�� !"#$%&
�� EéÜçëéÜçÜáëíáÇáåÉF�� !"#$%&
EåìÅäÉçëáÇÉ=ÇáéÜçëéÜ~íÉëF�� !"#E� JéÜçëéÜ~íÉF
�� !"#$%& EÇÉçñóåìÅäÉçëáÇÉ=íêáéÜçëéÜ~íÉëF
�� !"xPJRzE�NF�� !"#$%&'()*
�� !"#$%&'()�*+,-.kjOP�
�� !kjOPJeN��kjOPJeO�� !"#$%
����
� �
�� !"#$��%&'()*+$,-"
�� !"#$%&'()*+,-./0123
�� !"#$%&�'()�*+,-./01
�� !"#$%&'()*!"+,()-NVUU
��píÉÉÖ�� !"#$%kjOP��EåçãÉí~ëí~íáÅ
OP=ÖÉåÉF�� !"#$%&'hNTPR�� !"#
�� !"#$%&' kjOP�� !"#$%&
�� !"#$% kjOP�� !"#$%&��
��
��
�� �� ��
Tzu Chi Med J 2004 � 16 � No. 2NOM �� !
kamh�^�_��EãçåçãÉêëF�� !"#$%&
�� !"#$xSz�� !"#$%&'()*+
�� !"#$"%$"&'$()*kjOPJeN�
�� !"#$%&'()*!+,-./01xTJ
NOz�� kjOPJeN�� !"#$%&'()*+
�� !"#$%&'()*+,-./xTIUz��
ok^�� !"#$%&'(&��)*+kjOPJ
eN�kjOPJeO�� ok^�� !"#$%�&
�� !"#$%&'(xNPINQz�� !"#$%
�� !"#$%&��'()*+,kjOPJeN�
kjOPJeO�� ok^�� !"#$%&'�()
�� !"#$%&'(xNRINSz�� !"#$%
�� !"kjOPJeN�� !"#$%&'()*
�� !"xNTz�� !"#$%&%'()*
kjOPJeN�� !"#$%&'()*+,-./
�� �!"#$%&'(
�� !"
�� !"#$%&'()OMMM��OMMO��
�� !"#$%&'()*+,-./0123
�� !"#$%&'()*#$+,-./01
�� !"#$%&'()*+,-./0QS��
�� !"#$% QP�P�� !"#$%&'(
PP�� UU�� !"#$ RQKPO�� !"#$%
�� !"#$OO�� !"#$%&'(NP��
�� !"#$%&' NN�� !"#E� ^g``
`~åÅÉê=pí~ÖÉ=j~åì~äI=páñíÜ=bÇáíáçå��F�� !"#
�� !"#$%&'( N�� !"#$%&'
�� !"#$%�&'()*&'+,-./0
�� !"#$%&'()*"NU��QS�� !
�� !"#EtÉää=aáÑÑÉêÉåíá~íÉÇF�� PU�� !
EjçÇÉê~íÉäó=~åÇ=mççêäó=aáÑÑÉêÉåíá~íÉÇF�� U�� !
�� !"#�$%&'()*+,-(P�E��
�� !"#$%F�
�� !"QS�� !"#$%�&'()*
�� !"#$%&'()*+,-./0123
�� !R�T�� !"#$%&'()"*)R
�� NMMB=uóäÉåÉ�� !"#$% NMMB��
�� VRB�� UMB�� TRB�� !" P��
�� !"#$%&'()*+,PM�� !"#
�� !"#$%&'()*+,-./0123
�� ! J�� EpJmF�� !"#$%&'(
�� !"qê~åëÇìÅíáçå=i~Äçê~íçêáÉë�� !"#$
�� kjOP�� kjOPJeN�� !"#$�%
�� !"#$%&'()*+,-./PBeOlO�
NR�� !"#$%& PM�� !"#$ ée=MKMN
�`áíê~íÉ=_ìÑÑÉê�� !"#!"R�� !"#$
éÜçëéÜçÜáëíáÇáåÉ
kìÅäÉçëáÇÉ=ÇáéÜçëéÜ~íÉë======H � JéÜçëéÜ~íÉ ==========================aÉçñóåìÅäÉçëáÇÉ=íêáéÜçëéÜ~íÉÇ
kamh
� NK=kamh�� !"#
�
� NK �� !E� ^g``=`~åÅÉê=pí~ÖÉ=j~åì~äI=páñíÜ=bÇáíáçå ��F�� !"#$%&'�()*+
�� !=EqF qN qO qP qQ~ qQÄ
�� ! S T P OT P
�� !"#$=EkF kM kN kO~ kOÄ kOÅ kP
�� ! OU R O P P R
�� !"#$%&=EjF jM jN
�� ! QS M
�� !=Epí~ÖÉF pí~ÖÉ=f pí~ÖÉ=ff pí~ÖÉ=fff pí~ÖÉ=fs^ pí~ÖÉ=fs_ pí~ÖÉ=fs`
�� ! R R S OV N M
�� !=Ecçääçï=ìé=éÉêáçÇF �� N � N � úO � �� O ��� ! NS NV NN
�� !"# �� ! �� !"�� ! QP P
�� ! �� ��
�� ! QR N
��
�� !kjOPJeN�� !"
Tzu Chi Med J 2004 � 16 � No. 2 �� ! NON
PM�� !"m_p�� !R�� !"# PT��
��mêáã~êó=^åíáÄçÇó��VM�� !"#m_p��
�� P�� � R�� !"#$% PT�� !"
iáåâ=^åíáÄçÇó�� OM�� !"#$m_p�� !
P �� � R �� !"#$% P T�� !"
píêÉé~îáÇáåJÜççêëÉê~ÇáëÜ=mÉêçñáÇ~ëÉ��OM�� !"
�� ! m_p�� ! P�� � R�� !"#
�� a ^ _ �� !"#$% P M �� !"#
`çìåíÉêJëí~áåÉÇ=EeÉã~íçñóäáåF�� !"#$%OM�
�� !"UMB�� VRB�� NMMB�� !"
��O�� !"#$%&'()NMMB=uóäÉåÉ��
�� �!"#$�%%&'()*+
�� !"#$%&'()*+,-.�qê~åëJ
ÇìÅíáçå=i~Äçê~íçêó�� ! eÉi~=`Éää�� !"#
�� !"#$%&'()%!"*+,(kjOPJ
eN�� !"#$%&'()*+%,-./01
�� !"#$%&'()*%&+,-m_p��
��mêáã~êó=~åíáÄáçÇó�� !"#$%&'()%
kjOPJeN�� !"#$%&'()*+,-".
�� E�O��PF�� !"#$%&'()*+
�� !"#$%&'(&')* ^lE^ãÉêáÅ~å
léíáÅ~äF�� !" QM�� !"#$R�� !
�� !"�#$% NMM�� !"#$%&'(
�� !"#$%&'()*%&+,-�� !
�� !"#$%&!"'( R�� !"#$%
�� !"#$%&'()*+,-
�� !"#$%&'()*+,-.é=Y=MKMR
�� !"#$%&'()
� �
�� !"#$%&'E� OF�� QS��
kjOPJeN�� !"#$%&'()"*#$)+
� OR�� RQKPB �
QP�� !"#$%&'()*OQ�� !"
RRKUB�P�� !"#$%&'()*N�� !
� PPKPB�� !"#$%&'()kjOPJeN��
�� !"#$%&'()*+,-./Eé=[=MKMRF
�
�� !"#$%OO�� !"#$%&'(
�� !"#$%&' NM�� !"#$ QRKRB�
NN �� !"#$%&'()*+,-./0 T
�� SPKSB� NP�� !"#$%&'()*+
�� !"#U�� SNKRB�� !"#$%&'
�E�� !"F� kjOPJeN�� !"#$%&'
�� !"#$%&'Eé=[=MKMRF�
�� !"#$%&'(PU�� !"#$%
�EtÉää=aáÑÑÉêÉåíá~íÉÇF�� !"#$%&'( OM
�� ROKSB � U�� !"#$%&EjçÇÉê~íÉäó
~åÇ=mççêäó=aáÑÑÉêÉåíá~íÉÇF�� !"#$%&'( R
�� S O K R B �� !"#$%&!'()*
kjOPJeN�� !"#$%&'()*+,-./
��Eé=[=MKMRF�
�� !"#$%&'()*+,-./01
�� !"#OU�� !"#$%&'()*+,
�� !"#NQ�� RMKMB�NU�� !"#$
�� !"#$%&'()* NN�� SNKNB��
�� !"#$%&'()*+,-kjOPJeN��
�OK= �� QMM�� !"kjOPJeN�� !"#$%
��
�PK= �� QMM�� !"kjOPJeN�� !"#$%
��
�� �� ��
Tzu Chi Med J 2004 � 16 � No. 2NOO �� !
�� !"#$%&'()*+,-./Eé=[=MKMRF
�
�� !"�#$%&'()#*+, P ��
�� !"#$%&'()*+,-./� O ��
�SSKTB�QP�� !"#$%&'()*+,-
�OP�� RPKRB�� !"#$%&'()*+
��kjOPJeN�� !"#$%&'()*+,-
�� !Eé=[=MKMRF�
� �
�� !"#$kjOPJeN�� !"#$%&
�� !"#$%&'()*+,-QS�� !"
RQKPB�� !kjOPJeN�� !"#$%&'(
�� !"#$%&'()*+,-./kjOPJeN
�� !"#$%&'()*+,-./0123
�� !"#$%&'()*+,-./0123
�� kjOPJeN�� !"#$%&'()*+
xNUJONz�� !"#$%&'()kjOPJeN��
�� !"#$%&'()*+,-./0123
�� !"#$%&'()kjOPJeN�� !
�� !"#$% kjOPJeN�� !"#$%&
�� !"#$��%&�'&�()&*+,-
�� !"#$%&'()*!+,-./01xTJ
NOz�� !"# kjOPJeN�� !"#$%&'
�� !"#$%&'()kjOPJeN�� !"#
�� !"#$%&'()*xOOz�� !"#$
kjOPJeN�� !"#$%&'()*+,-./
�� !"#$%&'()*+,-(./012
�� !"#$%&'()*+,-./0123
�� kjOPJeN�� !"#$%&'(xOPJOSz�
�� !"#$kjOPJeN�� !"#$%&'(
�� !"#$%&'()*+,'-./0xOTz�
�� !"#$%&'()*+,-./kjOPJeN
�� !"#$%&'()*+,-./0123
�� !"#$%&'()*+,-./0)12
�� �kjOPJeN�� !"#$%&'()*+
�� !"#$%&'()*+,-./0123
�� !"xOUIOVz�� !"#$%&'()*
��
� �
�� !"#$%&'()*+,-'./0
�� !"#$%&'(�)*+,-./"01
�� !"#$%&'()*+,�-#$".
�� !"#kjOPJeN�� !"#$%&'()
�� !"#$%&'()*+,-./012
��
�� !
� OK kjOPJeN�� !"
�� !"# kjOPJeN�� !"# kjOPJeN�� !"# �� !"
�� QS=ENMMBF ON=EQRKTBF OR=ERQKPBF kp
�� kp=EmZMKQSRQF
� =QP=ENMMBF NV=EQQKOBF OQ=ERRKUBF
� P=ENMMBF O=ESSKTBF N=EPPKPBF
�� kp=EmZMKQUTTF
�� OO=ENMMBF NO=ERQKRBF NM=EQRKRBF
� =NN=ENMMBF Q=EPSKQBF T=ESPKSBF
�� =NP=ENMMBF R=EPUKRBF U=ESNKRBF
�� ! kp=EmZMKSPTQF
�� PU=ENMMBF NU=EQTKRBF OM=EROKSBF
�� U=ENMMBF P=EPTKRBF R=ESOKRBF
�� !" kp=EmZMKQTOMF
�� OU=ENMMBF NQ=ERMKMBF NQ=ERMKMBF
�� NU=ENMMBF T=EPUKVBF NN=ESNKNBF
�� ! kp=EmZMKSUMVF
�� P=ENMMBF N=EPPKPBF O=ESSKTBF
�� QP=ENMMBF OM=EQSKRBF OP=ERPKRBF
�� !kjOPJeN�� !"
Tzu Chi Med J 2004 � 16 � No. 2 �� ! NOP
1. Steeg PS, Bevilacqua G, Kopper L, et al: Evidence fora novel gene associated with low tumor metastaticpotential. J Natl Cancer Inst 1988; 80:200-204.
2. Backer JM, Mendola CE, Kovesdi I, et al: Chromosomallocalization and nucleoside diphosphate kinase activityof human metastasis-suppressor gene, NM23-1 andNM23-2. Oncogene 1993; 8:497-502.
3. Agarwal RP, Robison B, Parks RE Jr: Nucleosidediphosphate kinase from human erythrocytes. MethodsEnzymol 1978; 51:376-386.
4. Engel M, Veron M, Theisinger B, et al: A novel serine/threonine-specific protein phospho-transferase activityof Nm23/nucleosididiphosphate kinase. Eur J Biochem1995; 234:200-207.
5. Gilles AM, Presecan E, Vonica A, Lascu I: Nuclepsidediphosphate kinase from human erythrocytes. Structuralcharacterization of the two polypetide chains respon-sible for heterogeneity of the hexameric enzyme. J BiolChem 1991; 266:8784-8789.
6. Stahl JA, Leone A, Rosengard AM, Porter L, King CR,Steeg PS: Identification of a second human nm23 gene,nm23-H2. Cancer Res 1991; 51:445-449.
7. Leone A, Flatow U, King CR, et al: Reduced incidence,metastatic potential, and cytokine resposiveness ofnm23 transfected melanoma cells. Cell 1991; 65:25-35.
8. Shi H, He R, Qiu W: Nm23 expression and its correla-tion with lung metastasis in human salivary adenoidcystic carcinoma. Zhonghua Kou Qiang Yi Xue Za Zhi1997; 32:4-6.
9. Jin H, Li J, Chen X: Significance of nm23 expression inmalignant carcinoma of salivary gland. Zhonghua KouQiang Yi Xue Za Zhi 1997; 32:341-343.
10. Leone A, Flatow U, Vanhoutte K, Steeg PS: Transfec-tion of human nm23-H1 into the human MDA-MB-435breast carcinoma cell line: Effect on tumor metastaticpotential, colonization and enzymatic activity. Oncogene1993; 8:2325-2333.
11. Bevilacqua G, Sobel ME, Liotta LA, Steeg PS: Associa-tion of low nm23 RNA levels in human primary infiltrat-ing ductal breast carcinomas with lymph node involve-ment and other histopathological indicators of high meta-static potential. Cancer Res 1989; 49:5185-5190.
12. Ayhan A, Yasui W, Yokozaki H, Kitadai Y, Tahara E:Reduced expression of nm23 protein is associated withadvance tumor stage and distant metastasis in humancolorectal carcinomas. Virchow Arch B cell pathol InclMol Pathol 1993; 63:213-218.
13. Hennessy C, Henry JA, May FE, Westley BR, Angus B,Lennard TW: Expression of the antimetastatic genenm23 in human breast cancer: An association with goodprognosis. J Natl Cancer Inst 1991; 83:281-285.
14. Nakayama T, Ohtsuru A, Nakao K, et al: Expression inhuman hepatocellular carcinoma of nucleoside diphos-phate kinase, a homologue of the NM23 gene product.J Natl Cancer Inst 1992; 84:1349-1354.
15. Hailat N, Keim DR, Melhem RF, et al: High level of p19/nm23 protein in neuroblastoma are associated withadvance stage disease and with N-myc gene
amplification. J Clin Invest 1991; 88:341-345.16. Engel M, Theisinger B, Seib T, et al: High levels of nm23-
H1 and nm23-H2 messenger RNA in human squamous-cell lung carcinoma are association with poor differen-tiation and advance tumor stage. Int J Cancer 1993; 55:357-379.
17. Sastre-Garau X, Lacombe ML, Jouve M, Veron M,Magdelenat H: Nucleoside diphosphate kinase/NM23expression in breast cancer: Lack of correlation withlymphonode metastasis. Int J Cancer 1992; 50:533-538.
18. Salerno M, Ouatas T, Palmieri D, Steeg PS: Inhibitionof signal transduction by the nm23 metastasis sup-pressor: Possible mechanisms. Clin Exp Metastasis2003; 20:3-10.
19. Fischbach MA, Settleman J: Specific biochemical inac-tivation of oncogenic ras proteins by nucleoside diphos-phate kinase. Cancer Res 2003; 63:4089-4094.
20. Hartsough MT, Morrison DK, Salerno M, et al: Nm23-H1 metastasis suppressor phosphorylation of kinasesuppressor of Ras via a histidine protein kinase pathway.J Biol Chem 2002; 277:32389-32399.
21. Liu F, Zhang Y, Zhang XY, Chen HL: Transfection ofthe nm23-H1 gene into human hepatocarcinoma cellline inhibits the expression of sialyl Lewis X, alpha1,3fucosyltransferase VII, and metastatic potential. J Can-cer Res Clin Oncol 2002; 128:189-196.
22. Gohring UJ, Eustermann I, Becker M, Neuhaus W, ReinDT, Schondorf T: Lack of prognostic significance ofnm23 expression in human primary breast cancer. OncolReports 2002; 9:1205-1208.
23. Takes RP, Baatenburg de Jong RJ, Wijffels K, SchuuringE, Litvinov SV: Expression of genetic markers in lymphnode metastases compared with their primary tumoursin head and neck cancer. J Pathol 2001; 194:298-302.
24. Song AU, Mais DD, Groo S, Wright JR, Yoshida GY:Expression of nm23 antimetastatic gene product in headand neck squamous cell carcinoma. Otolaryngol HeadNeck Surg 2000; 122:96-99.
25. Takes RP, Baatenburg de Jong RJ, Schuuring E,Litvinov SV, Hermans J, Van Krieken JH: Differencesin expression of oncogenes and tumor suppressor genesin different sites of head and neck squamous cell. Anti-cancer Res 1998; 18:4793-4800.
26. Miyazaki H: Expression and anti-metastatic potential ofnm 23/NDP kinase in human head and neck cancercells. Kokubyo Gakkai Zasshi 1998; 65:189-195.
27. Pavelic K, Kapitanovic S, Radosevic S, et al: Increasedactivity of nm23-H1 gene in squamous cell carcinomaof the head and neck is associated with advanced dis-ease and poor prognosis. J Mol Med 2000; 78:111-118.
28. Chen SL, Wu YS, Shieh HY, Yen CC, Shen JJ, Lin KH:P53 is a regulator of the metastasis suppressor geneNm23-H1. Mol Carcinog 2003; 36:204-214.
29. Ray S, Chattopadhyay N, Mitra A, Siddiqi M, ChatterjeeA: Curcumin exhibits antimetastatic properties by modu-lating integrin receptors, collagenase activity, and ex-pression of Nm23 and E-cadherin. J Environ PatholToxicol Oncol 2003; 22:49-58.
�� �� ��
Tzu Chi Med J 2004 � 16 � No. 2NOQ �� !
Immunohistochemical Evaluation of the NM23-H1 Gene Product in the
Oral Squamous Cell Carcinoma
Tze-Ta Huang, Jeh-En Tzeng1, Young-Kie Wang2
Department of Oral and Maxillofacial Surgery, Pathology1, Buddhist Dalin Tzu Chi General Hospital, Chiayi, Taiwan;
Department of Oral and Maxillofacial Surgery2, Taichung Veterans General Hospital, Taichung, Taiwan
ABSTRACTObjective: To evaluate the relationship between the MN23-H1 gene product and the disease of oral squamous cellcarcinoma. Materials and Methods: Fourty-six subjects who had received tumor ablation surgery and had completemedical records of the oral squamous cell carcinoma (male/female: 43/3; age: 33-88 years old, average, 54.32 yearsold; buccal mucosa, 22 cases; tongue, 13 cases; and gingival, 11 cases) were selected from 2000 to 2002 in BuddhistDalin Tzu Chi General Hospital, Taiwan. Expressions of the NM23-H1 gene in these tumor cells were analyzedimmunohistochemically. Results: The results show that the expression of the NM23-H1 gene was slightly increased inthese 46 cases. There were 25 cases (54.3%) which exhibited positive staining. After analyzing these data with X2
analysis, expression of the NM23-H1 gene was not statistically related to gender (male or female), site (buccal mucosa,tongue, or gingiva), tumor differentiation (well or non-well), neck lymph nodes metastasis (yes or no), or distantmetastasis (yes or no) (p > 0.05). Conclusions: This study shows that expression of the NM23-H1 gene was slightlyincreased in oral squamous cell carcinoma, but failed to show a clinically, the predictable relationship between necklymph node metastasis and NM23-H1 gene expression. (Tzu Chi Med J 2004; 16:119-124)
Key words: NM23 gene, metastasis suppressive gene, oral cancer, immunohistochemistry
Received: July 3, 2003, Revised: August 1, 2003, Accepted: August 29, 2003Address reprint requests and correspondence to: Dr. Tze-Ta Huang, Department of Oral and Maxillofacial Surgery, BuddhistDalin Tzu Chi General Hospital, 2, Min Sheng Road, Dalin, Chiayi, Taiwan
Recommended